An optimal control theory approach to non-pharmaceutical interventions

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Lin, Feng ^a   Muthuraman, Kumar ^b   Lawley, Mark ^a  

^a PURDUE UNIVERSITY   (United States)

^b Dept of Information Risk and Operations Management ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATION COEFFICIENT; COST EFFECTIVENESS ANALYSIS; EPIDEMIC; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; MATHEMATICAL ANALYSIS; MORTALITY; NON PHARMACEUTICAL INTERVENTIONS; OPTIMAL CONTROL THEORY; PROBABILITY; SENSITIVITY ANALYSIS; THEORY; DISEASE TRANSMISSION; ECONOMICS; INFLUENZA; METHODOLOGY; SENTINEL SURVEILLANCE; STATISTICAL MODEL;

COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; HEALTH POLICY; HUMANS; INFLUENZA, HUMAN; MODELS, STATISTICAL; SENTINEL SURVEILLANCE;

EID: 77649279736     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-32     Document Type: Article

References (48)

1. World Health Organization (WHO) WHO strategic action plan for pandemic influenza 2007, World Health Organization (WHO)., http://www.who.int/csr/resources/publications/influenza
2. Situation updates - Pandemic (H1N1) 2009. 2009, http://www.who.int/csr/disease/swineflu/updates/en/
3. Current WHO phase of pandemic alert. 2009, http://www.who.int/csr/disease/avian_influenza/phase/en/index.html
4. World now at the start of 2009 influenza pandemic. 2009, http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html
5. Stöhr K, Esveld M. Will vaccines be available for the next influenza pandemic?. Science 2004, 306(5705):2195-2196. 10.1126/science.1108165, 15618505.
6. Bell DM. Nonpharmaceutical interventions for pandemic influenza international measures. Emerg Infect Dis 2006, 12:81-87.
7. Centers for Disease Control and Prevention Intreim Pre-pandemic Planning Guidance: community strategy for pandemic influenza 2007, Centers for Disease Control and Prevention., http://www.pandemicflu.gov
8. World Health Organization (WHO) Writing Group Non-pharmaceutical interventions: their role in reducing transmission and spread 2005, World Health Organization (WHO) Writing Group., http://www.col.ops-oms.org/servicios/influenza/reunion/docs/WHO_intervenciones_no_farmacologicas.pdf
9. Safety of pandemic vaccines. 2009, http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/index.html
10. Germann TC, Kadau K, Longini IM, Macken CA. Mitigation strategies for pandemic influenza in the United State. PNAS 2006, 103(15):5935-5940. 10.1073/pnas.0601266103, 1458676, 16585506.
11. Bootsma MCJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. PNAS 2007, 104(18):7588-7593. 10.1073/pnas.0611071104, 1849868,1849868, 17416677.
12. Markel H, Stern AM, Navarro JA, Michalsen JR, Monto AS, DiGiovanni C. Nonpharmaceutical influenza mitigation strategies, US communities, 1918-1920 pandemic. Emerg Infect Dis 2006, 12(12):1961-1964.
13. Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedely AJ, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health intervention. Science 2003, 300:1961-1966. 10.1126/science.1086478, 12766206.
14. Centers for Disease Control and Prevention Use of quarantine to prevent transmission of Severe Acute Respiratory Syndrome - Taiwan, 2003. MMWR-Recomm-Rep 2003, 52(29):680-683. Centers for Disease Control and Prevention.
15. Novel H1N1 flu: CDC response. 2009, http://www.cdc.gov/h1n1flu/cdcresponse.htm
16. Glass RJ, Glass LM, Beyeler WE, Min HJ. Targeted social distancing design for pandemic influenza. Emerg Infect Dis 2006, 12(11):1671-1681.
17. Carrat F, Luong J, Lao H, Salle A, Lajaunie C, Wackernagel H. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Medicine 2006, 4(26). 1626479, 17059593.
18. Chowell G, Nishiura H, Bettencourt LMA. Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface 2006, 4:155-166.
19. Wu JT, Riley S, Fraser C, Leung GM. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Medicine 2006, 3:1532-1540.
20. Chowell G, Ammon CE, Hengartner NW, Hyman JM. Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: assessing the effects of hypothetical intervention. Journal of Theoretical Biology 2005, 241(2):193-204.
21. Longini IM, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004, 159(7):623-633. 10.1093/aje/kwh092, 15033640.
22. Ferguson NM, Derek C, Christophe F, James C, Philip C, Donald B. Strategies for mitigating an influenza pandemic. Nature 2006, 442:448-452. 10.1038/nature04795, 16642006.
23. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings D, et al. Containing pandemic influenza at the source. Science 2005, 309(5737):1083-1087. 10.1126/science.1115717, 16079251.
24. Webby RJ, Webster RG. Are we ready for pandemic influenza?. Science 2003, 302:1519-1522. 10.1126/science.1090350, 14645836.
25. Mills C, Robins J, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature 2004, 432:904-906. 10.1038/nature03063, 15602562.
26. Cauchemez S, Carrat F, Viboud C, Valleron J, Bolle PY. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med 2004, 23(22):3469-3487. 10.1002/sim.1912, 15505892.
27. Dushoff J, Plotkin JB, Levin SA, Earn DJD. Dynamical resonance can account for seasonality of influenza epidemics. PNAS 2004, 101(48):16915-16916. 10.1073/pnas.0407293101, 534740, 15557003.
28. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clinical Infectious Diseases 2003, 37:1094-1101. 10.1086/378292, 14523774.
29. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, et al. Transmission dynamics of Severe Acute Respiratory Syndrome. Science 2003, 300:1966-1970. 10.1126/science.1086616, 2760158, 12766207.
30. Wai T, Turinici G, Danchin A. A double epidemic model for the SARS propagation. BMC Infectious Diseases 2003, 3(19).
31. Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLoS Medicine 2005, 2:1532-1540.
32. Elderd BO, Dukic VM, Dwyer G. Uncertainty in predictions of diseases spread and public health responses to bioterrorism and emerging diseases. PNAS 2006, 103(42):15639-15697.
33. Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. PNAS 2002, 99(16):10935-10940. 10.1073/pnas.162282799, 125076, 12118122.
34. Riley S, Ferguson NM. Smallpox transmission and control: Spatial dynamics in Great Britain. PNAS 2007, 103(33):12637-12642.
35. Cooper B. Poxy models and rash decisions. PNAS 2006, 103(33):12221-12222. 10.1073/pnas.0605502103, 1567860, 16894142.
36. Clancy D. Optimal intervention for epidemic models with general infection and removal rate functions. J Math Biol 1999, 39:309-331. 10.1007/s002850050193, 10550576.
37. Sethi SP, Staats PW. Optimal control of some simple deterministic epidemic models. J Oper Res Soc 1978, 29(2):129-136.
38. Sethi SP. Optimal quarantine programmes for controlling an epidemic spread. J Oper Res Soc 1978, 29(3):265-268.
39. Wickwire K. Optimal immunization rules for an epidemic with recovery. Adv Appl Prob 1977, 9(2):222-223.
40. Morton R, Wickwire KH. On the optimal control of a deterministic epidemic. Adv Appl Prob 1974, 6(4):622-635.
41. Behncke H. Optimal control of deterministic epidemics. Optim Control Appl Meth 2000, 21:269-285.
42. Bertsekas D. Dynamic Programming and Optimal Control 2007, Athena Scientific, 3.
43. Macki J, Strauss A. Introduction to Optimal Control Theory 1965, Springer, 1.
44. Bardi M, Capuzzo-Dolcetta I. Optimal Control and Viscosity Solutions of Hamilton-Jacobi-Bellman 1997, Springer, 1.
45. Handel A, Longini I, Antia R. What is the best control strategy for multiple infectious disease outbreaks?. Proc R Soc B 2006, 274:833837.
46. Blower S, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. International Statistical Review 1994, 62(2):229-243.
47. Sanchez M, Blower S. Uncertainty and sensitivity analysis of the basic reproductive rate: tuberculosis as an example. Am J Epidemiol 1997, 145(12):1127-1137.
48. Kajita E, Okano J, Bodine E, Layne S, Blower S. Modelling an outbreak of an emerging pathogen. Nature Reviews Microbiology 2007, 5:700-709. 10.1038/nrmicro1660, 17703226.